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• Myxedema coma is a severe and life threatening form of
decompensated hypothyroidism. It presents with multiple
organ dysfunction and progressive mental deterioration.
• Cases of myxedema coma usually occur in women with
significant mortality rate, 25-60% even when they are
under proper treatment.
• In the peer-reviewed literature, the incidence of
myxedema coma is 0.22 million cases per year.
• This case describes a male patient with myxedema
coma associated with visual hallucinations.






A 72-year-old Caucasian male with past medical 
history of hypothyroidism, coronary artery disease status 
post one stent, essential hypertension, right renal cell 
carcinoma status post nephrectomy on chemotherapy, 
and chronic kidney disease stage 4 had presented to the 
ED with weight gain, visual hallucinations for a week. He 
was taking levothyroxine 100 mcg daily, lisinopril 40 mg 
daily, clopidogrel 75 mg daily, aspirin 81 mg daily, and 
metoprolol 25 mg daily. On arrival to the emergency 
department, he was alert but not oriented and was 
confused. Physical examination revealed generalized 
edema more prominent bilaterally in lower extremities. 
His vital signs were stable with blood pressure 130/80 
mmHg, heart rate 72 beats/minute, respiratory rate 18 
breaths/minute, and temperature 97.9 F. 
Patient was subsequently admitted to the intensive 
care unit. Intensivist and nephrologist were consulted. 
The nephrologist started the patient on intravenous (IV) 
3% sodium chloride. At the same time, the intensivist 
placed him on thyroxine 50 mcg IV daily, liothyronine 5 
mcg orally (PO), and hydrocortisone 80 mg every six 
hours PO to rule out adrenal insufficiency. Both the 
thyroid hormone and mineralocorticoid were continued 
for three days. Cortisol level returned within normal limits 
and hydrocortisone was discontinued. 
On the third day, the sodium levels, liver enzymes, 
and mental status improved, and his thyroid hormone 
medication was switched to PO. Patient was intensive 
care unit for four days and then transferred to the 
medical floor. He was discharged home on PO thyroxine.
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• Laboratory results revealed a sodium level of 117
mEq/L, creatinine 2.4 mg/dl, aspartate aminotransferase
189 U/L, thyroid stimulating hormone (TSH) 75.70.
µU/mL, and free thyroxine (T4) 0.47 µU/mL.
• Cortisol level returned within normal limits .
• One of the most remarkable clinical manifestation of 
our patient was visual hallucination.
• From peer-reviewed literature, few cases of 
myxedema coma reported hallucinations. In these 
cases, patients have history of Hashimoto’s thyroiditis, 
thyroidectomy or medication noncompliance6,7,8.
• In our case, a possible cause of myxedema coma 
could have been due to his concomitant treatment with 
levothyroxine and the chemotherapy drug for renal cell 
carcinoma.
• Most of the time, in the emergency department, thyroid 
stimulating hormone test is not ordered because it is 
not considered as part of the tests ordered in an acute 
setting.
• It is important to check for thyroid abnormalities as part 
of the differential diagnosis in patients who present 
with acute changes in behavior or cognition as they 
can prompt treatment quicker.
• The prognosis for myxedema coma is difficult to 
establish due to the small number of cases reported.
• This disorder is best managed by an inter-professional 
team to enable prompt diagnosis and management. 
Identifying a precipitating cause is imperative. 
• Endocrinology consult is necessary on clinical 
suspicion.
• This case draws attention that prompt diagnosis by 
checking thyroid function tests and rapid 
intervention are essential in reducing mortality.
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Figure 1: Clinical manifestations commonly found in 
myxedema coma (HealthJade).
